German health secretary supports insurance gene test ban:
This article was originally published in Clinica
Executive Summary
German parliamentary secretary for health Gudrun Schaich-Walch has said there is no reason to amend the law banning insurance companies from requiring obligatory gene tests from clients. She told the Frankfurter Allgemeine Sonntag Zeitung that the red-green coalition is particularly intent on preventing "genetic discrimination" by health and life insurance companies. Ms Schaich-Walch claimed that, were gene tests to be allowed, private insurers could take this opportunity to force potentially dangerous clients to join statutory health insurers in order to protect their own premium levels.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.